Related Experiment Video
Updated: Mar 25, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.4K
Cancer-Associated Venous Thromboembolism
Hazem Elewa1, Riham Elrefai2, Geoffrey D Barnes3
1College of Pharmacy, Qatar University, PO Box 2713, Doha, Qatar.
Current Treatment Options in Cardiovascular Medicine
|February 25, 2016
Summary
Cancer patients face high venous thromboembolism (VTE) risks. This review covers VTE epidemiology, risk factors, and treatment strategies, including low-molecular-weight heparin (LMWH), for cancer-associated VTE.
Area of Science:
- Oncology
- Hematology
- Cardiovascular Medicine
Background:
- Cancer patients have a significantly elevated risk of venous thromboembolism (VTE), a leading cause of mortality in this group.
- Both the malignancy itself and its treatments contribute to increased VTE risk.
- Individual VTE risk varies, necessitating identification of specific risk factors for incident and recurrent VTE.
Purpose of the Study:
- To review the epidemiology, pathophysiology, and risk stratification of cancer-associated VTE.
- To discuss current therapeutic strategies for cancer-associated VTE.
- To examine the evidence supporting VTE treatment in cancer patients.
Main Methods:
- Literature review of epidemiological data, pathophysiology, and clinical studies.
- Analysis of risk stratification systems for VTE in cancer patients.
- Evaluation of treatment guidelines and evidence for anticoagulants.
Main Results:
- A validated scoring system for recurrent VTE risk in cancer patients has been developed.
- Low-molecular-weight heparin (LMWH) is the recommended first-line anticoagulant for cancer-associated VTE.
- Direct oral anticoagulants (DOACs) and vitamin K antagonists (VKAs) are primary treatments for non-cancer VTE.
Conclusions:
- Understanding VTE risk factors is crucial for managing cancer patients.
- LMWH represents the standard of care for treating VTE in this population.
- Further research and risk stratification tools are essential for optimizing VTE management in oncology.
More Related Videos
Related Concept Videos
01:30Venous Thrombosis I: Introduction
668
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
668
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
432
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
432
01:29Venous Thrombosis III: Interprofessional Care
460
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
460
01:30Venous Thrombosis IV: Nursing Management
368
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
368
02:18Cancer
55.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.5K
01:26Varicose Veins II: Diagnostic Studies and Interprofessional Care
284
Varicose veins, or varicosities, develop when the valves in the veins, which control blood flow, weaken or damage. It causes blood to pool and the veins to enlarge. Understanding the clinical manifestations, diagnostic approaches, and management options for varicose veins is crucial for effective treatment and relief.Clinical manifestationsClinical manifestations of varicose veins include a heavy, achy feeling or pain after prolonged standing or sitting. This discomfort can often be relieved by...
284